Zobrazeno 1 - 10
of 433
pro vyhledávání: '"M. Unterrainer"'
Autor:
M. Unterrainer, C. Eze, H. Ilhan, S. Marschner, O. Roengvoraphoj, N. S. Schmidt-Hegemann, F. Walter, W. G. Kunz, P. Munck af Rosenschöld, R. Jeraj, N. L. Albert, A. L. Grosu, M. Niyazi, P. Bartenstein, C. Belka
Publikováno v:
Radiation Oncology, Vol 15, Iss 1, Pp 1-15 (2020)
Abstract Radiotherapy and radiation oncology play a key role in the clinical management of patients suffering from oncological diseases. In clinical routine, anatomic imaging such as contrast-enhanced CT and MRI are widely available and are usually u
Externí odkaz:
https://doaj.org/article/484dad0a5e324fbeb664b7c0b3ac5db3
Autor:
S. Rudisile, A. Gosewisch, V. Wenter, M. Unterrainer, G. Böning, F. J. Gildehaus, W. P. Fendler, C. J. Auernhammer, C. Spitzweg, P. Bartenstein, A. Todica, H. Ilhan
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background NETTER-1 trial demonstrated high efficacy and low toxicity of four cycles of Peptide Receptor Radionuclide Therapy (PRRT) in patients with metastasized NET. The present study evaluates the outcome of further PRRT cycles in the so
Externí odkaz:
https://doaj.org/article/b0ced27a889e4a45929580f8b04163d6
Autor:
Josef M. Unterrainer, Julia Petersen, Peter Schmidt, Mareike Ernst, Markus A. Wirtz, Anna C. Reinwarth, Felix Wicke, Jasmin Ghaemi Kerahrodi, Matthias Michal, Thomas Münzel, Jochem König, Karl J. Lackner, Norbert Pfeiffer, Oliver Tüscher, Peter R. Galle, Manfred Beutel, Philipp S. Wild
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-15 (2024)
Abstract Age-related cognitive decline has become an increasingly relevant public health issue. However, risk and protective factors of cognitive decline have yet to be investigated prospectively taking into account genetic, lifestyle, physical and m
Externí odkaz:
https://doaj.org/article/368c8c3ec35f41d98fd61e6d2b242222
Autor:
Ida Sonni, Andrei Gafita, Lena M. Unterrainer, Rejah M. Alano, Stephanie Lira, John Shen, Alexandra Drakaki, Tristan Grogan, Matthew B. Rettig, Johannes Czernin, Jeremie Calais
Publikováno v:
EJNMMI Research, Vol 13, Iss 1, Pp 1-8 (2023)
Abstract Background PSMA expression is influenced by hormonal status. We evaluated changes in PSA and whole-body 68Ga-PSMA-11 PET/CT (WB-PSMA PET) after initiation of androgen receptor signaling inhibitors (ARSi). Methods Prospectively enrolled patie
Externí odkaz:
https://doaj.org/article/fc9be906f81d4f2fb2a2b86d91fd4eaf
Autor:
Sandra Resch, Sarah Takayama Fouladgar, Mathias Zacherl, Gabriel T. Sheikh, Grigory Liubchenko, Mikhail Rumiantcev, Lena M. Unterrainer, Vera Wenter, Peter Bartenstein, Sibylle I. Ziegler, Harun Ilhan, Leonie Beyer, Guido Böning, Astrid Delker
Publikováno v:
EJNMMI Physics, Vol 10, Iss 1, Pp 1-16 (2023)
Abstract Background 177Lu-PSMA therapy has been successfully used to prolong the survival of patients with metastatic castration-resistant prostate cancer. Patient-specific dosimetry based on serial quantitative SPECT/CT imaging can support the under
Externí odkaz:
https://doaj.org/article/2ce067d4e88d47b7b2920f87feaee6ca
Autor:
Lukas Gold, Enio Barci, Matthias Brendel, Michael Orth, Jiying Cheng, Sabrina V. Kirchleitner, Laura M. Bartos, Dennis Pötter, Maximilian A. Kirchner, Lena M. Unterrainer, Lena Kaiser, Sibylle Ziegler, Lorraine Weidner, Markus J. Riemenschneider, Marcus Unterrainer, Claus Belka, Joerg-Christian Tonn, Peter Bartenstein, Maximilian Niyazi, Louisa von Baumgarten, Roland E. Kälin, Rainer Glass, Kirsten Lauber, Nathalie L. Albert, Adrien Holzgreve
Publikováno v:
Biomedicines, Vol 12, Iss 1, p 188 (2024)
Background: The translocator protein (TSPO) has been proven to have great potential as a target for the positron emission tomography (PET) imaging of glioblastoma. However, there is an ongoing debate about the potential various sources of the TSPO PE
Externí odkaz:
https://doaj.org/article/bab7c24b04b64509ad8004cad24a8c44
Autor:
Vinh Ngoc Bui, Lena M. Unterrainer, Matthias Brendel, Sophie C. Kunte, Adrien Holzgreve, Fabian Allmendinger, Peter Bartenstein, Frederick Klauschen, Marcus Unterrainer, Michael Staehler, Stephan Ledderose
Publikováno v:
Biomedicines, Vol 11, Iss 11, p 3095 (2023)
In renal cell carcinoma (RCC), accurate imaging methods are required for treatment planning and response assessment to therapy. In addition, there is an urgent need for new therapeutic options, especially in metastatic RCC. One way to combine diagnos
Externí odkaz:
https://doaj.org/article/84e096e7d1ae45318b188c585e1092ea
Autor:
Ralf S. Eschbach, Markus Hofmann, Lukas Späth, Gabriel T. Sheikh, Astrid Delker, Simon Lindner, Klaus Jurkschat, Carmen Wängler, Björn Wängler, Ralf Schirrmacher, Reinhold Tiling, Matthias Brendel, Vera Wenter, Franziska J. Dekorsy, Mathias J. Zacherl, Andrei Todica, Harun Ilhan, Freba Grawe, Clemens C. Cyran, Marcus Unterrainer, Johannes Rübenthaler, Thomas Knösel, Tanja Paul, Stefan Boeck, Christoph Benedikt Westphalen, Christine Spitzweg, Christoph J. Auernhammer, Peter Bartenstein, Lena M. Unterrainer, Leonie Beyer
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
PurposeSomatostatin analogues (SSA) are frequently used in the treatment of neuroendocrine tumours. Recently, [18F]SiTATE entered the field of somatostatin receptor (SSR) positron emission tomography (PET)/computed tomography (CT) imaging. The purpos
Externí odkaz:
https://doaj.org/article/3d44f66487cd4f03ae7b9ac67d9471d4
Autor:
Adrien Holzgreve, Hans Roland Dürr, Axel Stäbler, Mathias Kaemmerer, Lena M. Unterrainer, Amanda Tufman, Farkhad Manapov, Wolfgang G. Kunz, Marcus Unterrainer
Publikováno v:
Diagnostics, Vol 13, Iss 5, p 901 (2023)
A 54-year-old patient presented with progressive pain for one month in the second finger of the right hand with an emphasis on the proximal interphalangeal (PIP) joint. Subsequent magnetic resonance imaging (MRI) showed a diffuse intraosseous lesion
Externí odkaz:
https://doaj.org/article/a3e3cfb33209446d827b54dad5a04df9
Autor:
Lena M. Unterrainer, Leonie Beyer, Mathias J. Zacherl, Franz J. Gildehaus, Andrei Todica, Sophie C. Kunte, Adrien Holzgreve, Gabriel T. Sheikh, Annika Herlemann, Jozefina Casuscelli, Matthias Brendel, Nathalie L. Albert, Vera Wenter, Nina-Sophie Schmidt-Hegemann, Wolfgang G. Kunz, Clemens C. Cyran, Jens Ricke, Christian G. Stief, Peter Bartenstein, Harun Ilhan, Marcus Unterrainer
Publikováno v:
Biomedicines, Vol 10, Iss 5, p 946 (2022)
Background: PSMA-based alpha therapy using 225Ac-PSMA-I&T provides treatment for metastatic castration-resistant prostate cancer (mCRPC), even after the failure of 177Lu-PSMA radioligand therapy (RLT). In clinical routine, the total tumor volume (TTV
Externí odkaz:
https://doaj.org/article/d02aa058511c42dd87da2b5ea69d0784